Investors

BioLineRx is a pre-commercial-stage biopharmaceutical company pursuing life-changing therapies for people living with certain cancers and rare disease. Headquartered in Israel, with operations in the U.S., BioLineRx is driving innovative therapeutics with end-to-end expertise in drug development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

The company is advancing a pipeline of investigational medicines for patients with multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors.